Guggenheim Maintains Buy on CryoPort, Raises Price Target to $16

Benzinga Newsdesk www.benzinga.com Positive 79.9%

Neg 0% Neu 0% Pos 79.9%

Guggenheim analyst Subbu Nambi maintains CryoPort (NASDAQ:CYRX) with a Buy and raises the price target from $12 to $16.

Comments

No comments yet. Be the first!